Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Caixeta

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
American Heart Journal|February 15, 2011
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialAdriano Caixeta, George D Dangas, Roxana Mehran, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2017
Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trialsCarlos M Campos, Adriano Caixeta, Marcelo Franken, et al.
Arquivos Brasileiros De Cardiologia|May 4, 2022
Plasma Ceramides in Cardiovascular Disease Risk StratificationDébora L M Junqueira, Alline Stach, Adriano Caixeta, et al.
Einstein (Sao Paulo, Brazil)|October 15, 2025
Inflammatory response to elective percutaneous coronary intervention is related to myocardial injuryPriscilla Teixeira Céo Frisso, Henrique Trombini Pinesi, Fernando Ramos de Mattos, et al.
Revista Da Associacao Medica Brasileira (1992)|December 19, 2025
Cardiotoxic effects of pantoprazole in Wistar rats submitted to cardiac ischemia and reperfusionAdilson Costa Dos Santos, Celia Maria Camelo Silva, Erisvaldo Amarante de Araújo, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialsRoxana Mehran, Stuart Pocock, Eugenia Nikolsky, et al.
The American Journal of Cardiology|December 25, 2012
Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial)Alf Inge Larsen, Dennis W T Nilsen, Jennifer Yu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 31, 2018
Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registriesAdriano Caixeta, Carlos M Campos, Cordula Felix, et al.
Journal of Thrombosis and Thrombolysis|March 28, 2014
Influence of gender on the risk of death and adverse events in patients with acute myocardial infarction undergoing pharmacoinvasive strategyEduardo Lanaro, Adriano Caixeta, Juliana A Soares, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 19, 2021
Prognostic role of neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing to pharmaco-invasive strategyFernando Tavares, Pedro I M Moraes, José Marconi Souza, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
American Heart Journal|February 15, 2011
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialAdriano Caixeta, George D Dangas, Roxana Mehran, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2017
Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trialsCarlos M Campos, Adriano Caixeta, Marcelo Franken, et al.
Arquivos Brasileiros De Cardiologia|May 4, 2022
Plasma Ceramides in Cardiovascular Disease Risk StratificationDébora L M Junqueira, Alline Stach, Adriano Caixeta, et al.
Einstein (Sao Paulo, Brazil)|October 15, 2025
Inflammatory response to elective percutaneous coronary intervention is related to myocardial injuryPriscilla Teixeira Céo Frisso, Henrique Trombini Pinesi, Fernando Ramos de Mattos, et al.
Revista Da Associacao Medica Brasileira (1992)|December 19, 2025
Cardiotoxic effects of pantoprazole in Wistar rats submitted to cardiac ischemia and reperfusionAdilson Costa Dos Santos, Celia Maria Camelo Silva, Erisvaldo Amarante de Araújo, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialsRoxana Mehran, Stuart Pocock, Eugenia Nikolsky, et al.
The American Journal of Cardiology|December 25, 2012
Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial)Alf Inge Larsen, Dennis W T Nilsen, Jennifer Yu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 31, 2018
Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registriesAdriano Caixeta, Carlos M Campos, Cordula Felix, et al.
Journal of Thrombosis and Thrombolysis|March 28, 2014
Influence of gender on the risk of death and adverse events in patients with acute myocardial infarction undergoing pharmacoinvasive strategyEduardo Lanaro, Adriano Caixeta, Juliana A Soares, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 19, 2021
Prognostic role of neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing to pharmaco-invasive strategyFernando Tavares, Pedro I M Moraes, José Marconi Souza, et al.
Pageof 12